← Back to Search

Anthropometric Measurements; Tissue Samples for Acid Reflux

N/A
Waitlist Available
Led By Prasad G Iyer, MD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
No Placebo-Only Group

Summary

Is waist to hip ratio (WHR), waist circumference (WC), (as markers of visceral adiposity) associated with an increase in acidic and non acidic reflux as well as systemic inflammation involving esophageal mucosa, thereby increasing esophageal injury and predisposing to subsequent development of Barrett's esophagus (BE)?

Eligible Conditions
  • Acid Reflux

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Correlate Anthropometry with number of acid reflux episodes

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Anthropometric Measurements; Tissue SamplesExperimental Treatment2 Interventions
All participants will have their waist circumference and waist to hip ratio taken as a measurement of central obesity. Participants undergoing clinically indicated upper endoscopy and who consent to providing tissue samples will have 8 tissue samples taken for future research purposes.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Tissue samples
2013
Completed Phase 2
~180

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,329 Previous Clinical Trials
3,059,615 Total Patients Enrolled
Prasad G Iyer, MDPrincipal InvestigatorMayo Clinic
5 Previous Clinical Trials
1,980 Total Patients Enrolled
~7 spots leftby Nov 2025